{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T07:45:39Z","timestamp":1761291939707},"reference-count":188,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[1999,5,1]],"date-time":"1999-05-01T00:00:00Z","timestamp":925516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[1999,5]]},"DOI":"10.1016\/s0163-7258(98)00053-9","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T02:34:30Z","timestamp":1027650870000},"page":"169-193","source":"Crossref","is-referenced-by-count":60,"title":["Small Molecule Inhibitors of Tumor-Promoted Angiogenesis, Including Protein Tyrosine Kinase Inhibitors"],"prefix":"10.1016","volume":"82","author":[{"given":"James M","family":"Hamby","sequence":"first","affiliation":[]},{"given":"H.D.Hollis","family":"Showalter","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0163-7258(98)00053-9_BIB1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/jnci\/6.1.73","article-title":"Vascular reactions of normal and malignant tissues in vivo. I. Vascular reactions of mice to wounds and normal and neoplastic transplants","volume":"6","author":"Algire","year":"1946","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB2","first-page":"687","article-title":"Antiangiogenic therapy and dermatology","volume":"33","author":"Arbiser","year":"1997","journal-title":"Drugs Today"},{"key":"10.1016\/S0163-7258(98)00053-9_BIB3","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/BF03401744","article-title":"Curcumin is an in vivo inhibitor of angiogenesis","volume":"4","author":"Arbiser","year":"1998","journal-title":"Mol. Med."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB4","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1089\/hyb.1998.17.185","article-title":"An anti-human VEGF monoclonal antibody, MV833, that exhibits potent anti-tumor activity in vivo.","volume":"17","author":"Asano","year":"1998","journal-title":"Hybridoma"},{"key":"10.1016\/S0163-7258(98)00053-9_BIB5","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0165-6147(98)01211-5","article-title":"Antiangiogenic tumor therapy","volume":"19","author":"Augustin","year":"1998","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB6","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1517\/13543776.6.12.1305","article-title":"Recent advances in the field of matrix metalloproteinase inhibitors","volume":"6","author":"Beckett","year":"1996","journal-title":"Expert Opin. Ther. Patents"},{"key":"10.1016\/S0163-7258(98)00053-9_BIB7","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1200\/JCO.1997.15.2.781","article-title":"Phase I clinical and pharmacokinetic study of oral carboxyamidotriazole, a signal transduction inhibitor","volume":"15","author":"Berlin","year":"1997","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB8","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/35064","article-title":"Tumor regression after endostatin therapy","volume":"391","author":"Black","year":"1998","journal-title":"Nature"},{"key":"10.1016\/S0163-7258(98)00053-9_BIB9","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/37126","article-title":"Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance","volume":"390","author":"Boehm","year":"1997","journal-title":"Nature"},{"key":"10.1016\/S0163-7258(98)00053-9_BIB10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1097-0045(19980401)35:1<1::AID-PROS1>3.0.CO;2-O","article-title":"Neutralizing anti-vascular endothelial growth factor antibody completely inhibits angiogenesis and growth of human prostate carcinoma micro tumors in vivo.","volume":"35","author":"Borgstrom","year":"1998","journal-title":"Prostate"},{"key":"10.1016\/S0163-7258(98)00053-9_BIB11","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0065-230X(08)60862-3","article-title":"How tumors become angiogenic","volume":"69","author":"Bouck","year":"1996","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB12","first-page":"2288","article-title":"Adenovirus-mediated wild-type p53 gene transfer down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human colon cancer","volume":"58","author":"Bouvet","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02785914","article-title":"The matrix metalloproteinases and their inhibitors in pancreatic cancer","volume":"21","author":"Bramhall","year":"1997","journal-title":"Int. J. Pancreatol."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB14","first-page":"1952","article-title":"Vascular endothelial growth factor as a marker of tumor endothelium","volume":"58","author":"Brekken","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB15","first-page":"714","article-title":"Delay of wound healing by the angiogenesis inhibitor TNP-470","volume":"48","author":"Brem","year":"1997","journal-title":"Surg. Forum"},{"key":"10.1016\/S0163-7258(98)00053-9_BIB16","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1517\/14728214.3.1.279","article-title":"Current progress towards the development of tyrosine kinase inhibitors as anticancer agents","volume":"3","author":"Bridges","year":"1998","journal-title":"Emerging Drugs"},{"key":"10.1016\/S0163-7258(98)00053-9_BIB17","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/BF00437471","article-title":"Cell adhesion molecules in angiogenesis","volume":"15","author":"Brooks","year":"1996","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB18","unstructured":"Brooks, P. and Cheresh, D. A. (1997) Methods and compositions useful for inhibition of angiogenesis. World Patent Application WO 9745447."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB19","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1126\/science.7512751","article-title":"Requirement of vascular integrin \u03b1v\u03b23 for angiogenesis","volume":"264","author":"Brooks","year":"1994","journal-title":"Science"},{"key":"10.1016\/S0163-7258(98)00053-9_BIB20","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/bjc.1998.430","article-title":"Exploiting tumor hypoxia and overcoming mutant p53 with tirapazamine","volume":"77","author":"Brown","year":"1998","journal-title":"Br. J. Cancer"},{"key":"10.1016\/S0163-7258(98)00053-9_BIB21","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0968-0004(97)01074-8","article-title":"Molecular mechanisms of blood vessel formation","volume":"22","author":"Bussolino","year":"1997","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB22","first-page":"1298","article-title":"Molecular mediators of angiogenesis in bladder cancer","volume":"58","author":"Campbell","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB23","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1016\/S0959-8049(96)00388-7","article-title":"TNP-470 (AGM-1470)","volume":"32A","author":"Castronovo","year":"1996","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/S0163-7258(98)00053-9_BIB24","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1517\/13543784.6.12.1867","article-title":"AL-3789","volume":"6","author":"Clark","year":"1997","journal-title":"Expert Opin. Invest. Drugs"},{"key":"10.1016\/S0163-7258(98)00053-9_BIB25","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1016\/S0960-894X(97)00445-9","article-title":"Discovery and structure-activity studies of a novel series of pyrido[2,3-d]pyrimidine tyrosine kinase inhibitors","volume":"7","author":"Connolly","year":"1997","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB26","first-page":"58","article-title":"Of mice and men","volume":"May 18, 131","author":"Cowley","year":"1998","journal-title":"Newsweek"},{"key":"10.1016\/S0163-7258(98)00053-9_BIB27","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/nm1097-1137","article-title":"A secreted FGF-binding protein can serve as the angiogenic switch in human cancer","volume":"3","author":"Czubayko","year":"1997","journal-title":"Nature Med."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB28","unstructured":"D\u2019Amato, R. (1997) Methods and compositions for inhibition of angiogenesis. United States Patent 5629327."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB29","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1073\/pnas.91.9.4082","article-title":"Thalidomide is an inhibitor of angiogenesis","volume":"91","author":"D\u2019Amato","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0163-7258(98)00053-9_BIB30","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1126\/science.7521539","article-title":"Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1","volume":"265","author":"Dameron","year":"1994","journal-title":"Science"},{"key":"10.1016\/S0163-7258(98)00053-9_BIB31","series-title":"Cellular and Molecular Pathogenesis","first-page":"79","article-title":"Regulation of angiogenesis and wound repair. Interactive role of the matrix and growth factors","author":"Davidson","year":"1996"},{"key":"10.1016\/S0163-7258(98)00053-9_BIB32","series-title":"Tumour Angiogenesis","first-page":"343","article-title":"Targeting the tumor endothelium using specific antibodies","author":"Derbyshire","year":"1997"},{"key":"10.1016\/S0163-7258(98)00053-9_BIB33","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1200\/JCO.1998.16.4.1444","article-title":"Fumagillin analog in the treatment of Kaposi\u2019s sarcoma","volume":"16","author":"Dezube","year":"1998","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB34","first-page":"96","article-title":"Evaluation of the effects of PD166285 and PD173074 on in vitro and in vivo angiogenesis","volume":"39","author":"Dimitroff","year":"1998","journal-title":"Proc. Am. Assoc. Cancer Res."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB35","first-page":"1329","article-title":"Choriocarcinoma","volume":"41","author":"Ehrmann","year":"1968","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB36","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1038\/sj.onc.1201090","article-title":"Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia","volume":"14","author":"Enholm","year":"1997","journal-title":"Oncogene"},{"key":"10.1016\/S0163-7258(98)00053-9_BIB37","series-title":"Tumour Angiogenesis","first-page":"185","article-title":"The role of vascular endothelial growth factor in the regulation of blood vessel growth","author":"Ferrara","year":"1997"},{"key":"10.1016\/S0163-7258(98)00053-9_BIB38","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/j.1875-9114.1997.tb03680.x","article-title":"The pharmacokinetics of TNP-470, a new angiogenesis inhibitor","volume":"17","author":"Figg","year":"1997","journal-title":"Pharmacotherapy"},{"key":"10.1016\/S0163-7258(98)00053-9_BIB39","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1056\/NEJM197111182852108","article-title":"Tumor angiogenesis","volume":"285","author":"Folkman","year":"1971","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB40","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/00000658-197203000-00014","article-title":"Anti-angiogenesis","volume":"175","author":"Folkman","year":"1972","journal-title":"Ann. Surg."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB41","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0065-230X(08)60946-X","article-title":"Tumor angiogenesis","volume":"43","author":"Folkman","year":"1985","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB42","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nm0195-27","article-title":"Angiogenesis in cancer, vascular, rheumatoid and other disease","volume":"1","author":"Folkman","year":"1995","journal-title":"Nature Med."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB43","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1126\/science.2432664","article-title":"Angiogenic factors","volume":"235","author":"Folkman","year":"1987","journal-title":"Science"},{"key":"10.1016\/S0163-7258(98)00053-9_BIB44","doi-asserted-by":"crossref","first-page":"10931","DOI":"10.1016\/S0021-9258(19)49853-0","article-title":"Angiogenesis","volume":"267","author":"Folkman","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB45","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1084\/jem.133.2.275","article-title":"Isolation of a tumor factor responsible for angiogenesis","volume":"133","author":"Folkman","year":"1971","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB46","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1126\/science.6192498","article-title":"Angiogenesis inhibition and tumor regression caused by heparin or a heparin fragment in the presence of cortisone","volume":"221","author":"Folkman","year":"1983","journal-title":"Science"},{"key":"10.1016\/S0163-7258(98)00053-9_BIB47","first-page":"560","article-title":"SU5416","volume":"39","author":"Fong","year":"1998","journal-title":"Proc. Am. Assoc. Cancer Res."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB48","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/368237a0","article-title":"The endogenous estrogen metabolite 2-methoxyestradiol inhibits angiogenesis and suppresses tumor growth","volume":"368","author":"Fotsis","year":"1994","journal-title":"Nature"},{"key":"10.1016\/S0163-7258(98)00053-9_BIB49","unstructured":"Freskos, J. N., Abbas, Z. S., Decrescenzo, G. A., Getman, D. P., Heintz, R. M., Mischke, B. V. and McDonald, J. J. (1998) Thiol sulfone metalloprotinease inhibitors. World Patent Application WO 9803164."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB50","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/anie.199705881","article-title":"Integrin antagonists and other low molecular weight compounds as inhibitors of angiogenesis","volume":"36","author":"Giannis","year":"1997","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB51","first-page":"38","article-title":"The hope & the hype","volume":"May 18, 151","author":"Gorman","year":"1998","journal-title":"Time"},{"key":"10.1016\/S0163-7258(98)00053-9_BIB52","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1023\/A:1005770612294","article-title":"An overview of clinical trials involving inhibitors of angiogenesis and their mechanism of action","volume":"15","author":"Gradishar","year":"1997","journal-title":"Invest. New Drugs"},{"key":"10.1016\/S0163-7258(98)00053-9_BIB53","first-page":"111","article-title":"Tumor angiogenesis","volume":"41","author":"Greenblatt","year":"1968","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB54","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1051\/jcp:1998196","article-title":"Radioresistance linked to hypoxia","volume":"95","author":"Guichard","year":"1998","journal-title":"J. Chim. Phys. Phys. Chim. Biol."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB55","first-page":"3673","article-title":"Failure of thalidomide to inhibit tumor growth and angiogenesis in vivo.","volume":"16","author":"Gutman","year":"1996","journal-title":"Anticancer Res."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB56","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0065-7743(08)60463-7","article-title":"Inhibition of matrix metalloproteinases","volume":"31","author":"Hagmann","year":"1996","journal-title":"Annu. Rep. Med. Chem."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB57","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0940-2993(97)80020-6","article-title":"Therapeutic efficacy of the angiogenesis inhibitor O-(chloroacetylcarbamoyl) fumagillol (TNP-470; AGM-1470) for human anaplastic thyroid carcinoma in nude mice","volume":"49","author":"Hama","year":"1997","journal-title":"Exp. Toxicol. Pathol."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB58","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1021\/jm970367n","article-title":"Structure-activity relationships for a novel series of pyrido[2,3-d]pyrimidine tyrosine kinase inhibitors","volume":"40","author":"Hamby","year":"1997","journal-title":"J. Med. Chem."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB59","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0092-8674(00)80108-7","article-title":"Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis","volume":"86","author":"Hanahan","year":"1996","journal-title":"Cell"},{"key":"10.1016\/S0163-7258(98)00053-9_BIB60","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1016\/S0959-8049(96)00401-7","article-title":"Transgenic mouse models of tumor angiogenesis","volume":"32A","author":"Hanahan","year":"1996","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/S0163-7258(98)00053-9_BIB61","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1600-0609.1997.tb01671.x","article-title":"Effects of TNP-470, a potent angiogenesis inhibitor, on growth of hematopoietic progenitors","volume":"58","author":"Hasuike","year":"1997","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB62","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nm0297-177","article-title":"Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation","volume":"3","author":"Helmlinger","year":"1997","journal-title":"Nature Med."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB63","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/nm0295-149","article-title":"Dormancy of micrometastases","volume":"1","author":"Holmgren","year":"1995","journal-title":"Nature Med."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB64","first-page":"891","article-title":"Vascularization of the Brown-Pearce rabbit epithelioma transplant as seen in the transparent ear chamber","volume":"42","author":"Ide","year":"1939","journal-title":"Am. J. Roentgenol."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB65","first-page":"407","article-title":"A suppressive effect of an angiogenesis inhibitor TNP-470 on hepatocarcinogenesis in rats","volume":"6","author":"Ikebe","year":"1997","journal-title":"Cells Hepatic Sinusoid"},{"key":"10.1016\/S0163-7258(98)00053-9_BIB66","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1349-7006.1998.tb00542.x","article-title":"Suppressive effect of the angiogenesis inhibitor TNP-470 on the development of carcinogen-induced hepatic nodules in rats","volume":"89","author":"Ikebe","year":"1998","journal-title":"Jpn. J. Cancer Res."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB67","series-title":"Cancer Therapeutics","first-page":"283","article-title":"Discovery of TNP-470 and other angiogenesis inhibitors","author":"Ingber","year":"1997"},{"key":"10.1016\/S0163-7258(98)00053-9_BIB68","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/348555a0","article-title":"Synthetic analogs of fumagillin that inhibit angiogenesis and suppress tumor growth","volume":"348","author":"Ingber","year":"1990","journal-title":"Nature"},{"key":"10.1016\/S0163-7258(98)00053-9_BIB69","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/sj.bjp.0701493","article-title":"Tranilast inhibits the proliferation, chemotaxis and tube formation of human microvascular endothelial cells in vitro and angiogenesis in vivo.","volume":"122","author":"Isaji","year":"1997","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB70","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1096\/fasebj.11.6.9194526","article-title":"The codependence of angiogenesis and chronic inflammation","volume":"11","author":"Jackson","year":"1997","journal-title":"FASEB J."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB71","first-page":"687","article-title":"Pharmacological effects of SB 220025, a selective inhibitor of P38 mitogen-activated protein kinase, in angiogenesis and chronic inflammatory disease models","volume":"284","author":"Jackson","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB72","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1023\/A:1018470709523","article-title":"An examination of the effects of hypoxia, acidosis, and glucose starvation on the expression of metastasis-associated genes in murine tumor cells","volume":"15","author":"Jang","year":"1997","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/S0163-7258(98)00053-9_BIB73","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0305-7372(97)90014-1","article-title":"Inhibition of malignant angiogenesis","volume":"23","author":"Jekunen","year":"1997","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB74","first-page":"1054","article-title":"Potentiation of the antiangiogenic ability of Linomide by androgen ablation involves down-regulation of vascular endothelial growth factor in human androgen-responsive prostatic cancers","volume":"57","author":"Joseph","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB75","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/(SICI)1097-0215(19970529)71:5<838::AID-IJC23>3.0.CO;2-2","article-title":"Effect of angiogenesis inhibitor TNP-470 on the progression of human gastric cancer xenotransplanted into nude mice","volume":"71","author":"Kanai","year":"1997","journal-title":"Int. J. Cancer"},{"key":"10.1016\/S0163-7258(98)00053-9_BIB76","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/(SICI)1097-0215(19971021)74:5<502::AID-IJC4>3.0.CO;2-7","article-title":"Combined analysis of p53 and vascular endothelial growth factor expression in colorectal carcinoma for determination of tumor vascularity and liver metastasis","volume":"74","author":"Kang","year":"1997","journal-title":"Int. J. Cancer"},{"key":"10.1016\/S0163-7258(98)00053-9_BIB77","first-page":"1391","article-title":"A novel approach to glioma gene therapy","volume":"12","author":"Ke","year":"1998","journal-title":"Int. J. Oncol."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB78","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nm0497-443","article-title":"Critical components of the female reproductive pathway are suppressed by the angiogenesis inhibitor AGM-1470","volume":"3","author":"Klauber","year":"1997","journal-title":"Nature Med."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB79","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0248-4900(97)82317-9","article-title":"Angiogenesis inhibitor SR 25989 upregulates thrombospondin-1 expression in human vascular endothelial cells and foreskin fibroblasts","volume":"89","author":"Klein-Soyer","year":"1997","journal-title":"Biol. Cell"},{"key":"10.1016\/S0163-7258(98)00053-9_BIB80","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/00001622-199711000-00012","article-title":"Inhibitors of tyrosine kinase","volume":"9","author":"Klohs","year":"1997","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB81","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1248\/bpb.21.346","article-title":"Inhibitory effects of tetrandrine on angiogenesis in adjuvant-induced chronic inflammation and tube formation of vascular endothelial cells","volume":"21","author":"Kobayashi","year":"1998","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB82","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1200\/JCO.1997.15.5.1985","article-title":"Phase I trial of micronized formulation carboxyamidotriazole in patients with refractory solid tumors","volume":"15","author":"Kohn","year":"1997","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB83","unstructured":"Kolata, G. (1998) A cautious awe greets drugs that eradicate tumors in mice. New York Times, May 3, Sect. 1: 1."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB84","first-page":"F217","article-title":"Protein tyrosine kinases and cancer","volume":"1333","author":"Kolibaba","year":"1997","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/S0163-7258(98)00053-9_BIB85","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/jnci\/90.4.273","article-title":"Gene therapy strategies for tumor antiangiogenesis","volume":"90","author":"Kong","year":"1998","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB86","first-page":"1501","article-title":"A phase I study of TNP-470 administered to patients with advanced squamous cell cancer of the cervix","volume":"3","author":"Kudelka","year":"1997","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/phrs.1997.0268","article-title":"Clinical research on antiangiogenic therapy","volume":"37","author":"Kuiper","year":"1998","journal-title":"Pharmacol. Res."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB88","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1517\/14728214.2.1.175","article-title":"Tumor-induced angiogenesis","volume":"2","author":"Kumar","year":"1997","journal-title":"Emerging Drugs"},{"key":"10.1016\/S0163-7258(98)00053-9_BIB89","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/0006-291X(91)91529-L","article-title":"Potent antiangiogenic action of AGM-1470","volume":"174","author":"Kusaka","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB90","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/bjc.1994.41","article-title":"Cytostatic inhibition of endothelial cell growth by the angiogenesis inhibitor TNP-470 (AGM-1470)","volume":"69","author":"Kusaka","year":"1994","journal-title":"Br. J. Cancer"},{"key":"10.1016\/S0163-7258(98)00053-9_BIB91","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1517\/13543784.7.6.1015","article-title":"American Association for Cancer Research 1998","volume":"7","author":"Lavelle","year":"1998","journal-title":"Expert Opin. Invest. Drugs"},{"key":"10.1016\/S0163-7258(98)00053-9_BIB92","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0163-7258(97)00052-1","article-title":"Protein kinase inhibitors","volume":"77","author":"Lawrence","year":"1998","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB93","first-page":"1021","article-title":"Influence of chemotherapeutic agents on the proliferation of capillary endothelial cells and tumor angiogenesis in murine bladder cancer","volume":"6","author":"Lee","year":"1995","journal-title":"Int. J. Oncol."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB94","first-page":"49","article-title":"Inhibition of tumor growth by targeting tumor endothelium using a soluble vascular endothelial growth factor receptor","volume":"9","author":"Lin","year":"1998","journal-title":"Cell Growth Differ."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB95","unstructured":"Lohmann, J-J. M., Hennequin, L. F. A. and Thomas, A. P. (1997) Preparation and antiangiogenic and\/or vascular permeability reducing effect of quinazoline derivatives. World Patent Application WO 9722596."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB96","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/00001813-199703000-00004","article-title":"in vitro inhibition of endothelial cell growth by the antiangiogenic drug AGM-1470 (TNP-470) and the anti-endoglin antibody TEC-11","volume":"8","author":"Maier","year":"1997","journal-title":"Anticancer Drugs"},{"key":"10.1016\/S0163-7258(98)00053-9_BIB97","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1126\/science.280.5366.996","article-title":"The power of the front page of the New York Times","volume":"280","author":"Marshall","year":"1998","journal-title":"Science"},{"key":"10.1016\/S0163-7258(98)00053-9_BIB98","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1126\/science.280.5366.997","article-title":"The roadblocks to angiogenesis blockers","volume":"280","author":"Marshall","year":"1998","journal-title":"Science"},{"key":"10.1016\/S0163-7258(98)00053-9_BIB99","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1182\/blood.V90.9.3322","article-title":"Induction of vascular endothelial growth factor by hypoxia is modulated by phosphatidylinositol 3-kinase\/Akt signaling pathway in Ha-ras-transformed cells through a hypoxia inducible factor-1 transcriptional element","volume":"90","author":"Mazure","year":"1997","journal-title":"Blood"},{"key":"10.1016\/S0163-7258(98)00053-9_BIB100","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S0014-5793(98)00122-7","article-title":"The endothelial receptor tyrosine kinase tie-1 is up-regulated by hypoxia and vascular endothelial growth factor","volume":"423","author":"McCarthy","year":"1998","journal-title":"FEBS Lett."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB101","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0022-5347(01)63092-1","article-title":"Angiogenesis inhibitor TNP-470 inhibits growth and metastasis of a hormone-independent rat prostatic-carcinoma cell-line","volume":"160","author":"Miki","year":"1998","journal-title":"J. Urol."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB102","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1046\/j.1365-2125.1998.00639.x","article-title":"Results of single and repeat dose studies of the oral matrix metalloproteinase inhibitor marimastat in healthy male volunteers","volume":"45","author":"Millar","year":"1998","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB103","doi-asserted-by":"crossref","first-page":"5896","DOI":"10.1093\/emboj\/17.20.5896","article-title":"Crystal structure of an angiogenesis inhibitor bound to the FGF receptor tyrosine kinase domain","volume":"17","author":"Mohammadi","year":"1998","journal-title":"EMBO J."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB104","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1023\/A:1012038930172","article-title":"Tumor vascular endothelium","volume":"14","author":"Molema","year":"1997","journal-title":"Pharm. Res."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB105","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1016\/S0006-2952(98)00011-2","article-title":"Tumor vasculature targeted therapies. Getting the players organized","volume":"55","author":"Molema","year":"1998","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB106","first-page":"2401","article-title":"Angiogenesis inhibitor TNP-470 augments the effect of repeated arterial ischemia on growth but does not affect take in a rat liver tumor model","volume":"17","author":"Moller","year":"1997","journal-title":"Anticancer Res."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB107","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S8756-3282(97)00248-2","article-title":"Antiangiogenic agent (TNP-470) inhibition of ectopic bone formation induced by bone morphogenetic protein-2","volume":"22","author":"Mori","year":"1998","journal-title":"Bone"},{"key":"10.1016\/S0163-7258(98)00053-9_BIB108","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1097\/00001813-199709000-00003","article-title":"Eriochrome Black T, structurally related to suramin, inhibits angiogenesis and tumor growth in vivo.","volume":"8","author":"Morris","year":"1997","journal-title":"Anticancer Drugs"},{"key":"10.1016\/S0163-7258(98)00053-9_BIB109","doi-asserted-by":"crossref","first-page":"473","DOI":"10.2174\/138161280305221010100940","article-title":"Inhibitors of tyrosine kinases involved in inflammation and autoimmune disease","volume":"3","author":"Myers","year":"1997","journal-title":"Curr. Pharm. Design"},{"key":"10.1016\/S0163-7258(98)00053-9_BIB110","first-page":"441","article-title":"Suppression of growth of Bomirski Ab melanoma and its metastasis in hamsters by angiogenesis inhibitor TNP-470","volume":"18","author":"Mysliwski","year":"1998","journal-title":"Anticancer Res."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB111","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3109\/03008209809028900","article-title":"Reduction in basic fibroblast growth factor mediated angiogenesis in vivo by linomide","volume":"37","author":"Nagler","year":"1998","journal-title":"Connect. Tissue Res."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB112","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0014-2999(97)01464-7","article-title":"Corticosteroids inhibit the expression of the vascular endothelial growth factor gene in human vascular smooth muscle cells","volume":"341","author":"Nauck","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB113","first-page":"965","article-title":"Thalidomide and chemotherapy combination","volume":"10","author":"Nguyen","year":"1997","journal-title":"Int. J. Oncol."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB114","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1699-0463.1997.tb00590.x","article-title":"Angiogenesis","volume":"105","author":"Norrby","year":"1997","journal-title":"APMIS"},{"key":"10.1016\/S0163-7258(98)00053-9_BIB115","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/bjc.1997.89","article-title":"Inhibition of lymph node metastasis by an anti-angiogenic agent, TNP-470","volume":"75","author":"Ohta","year":"1997","journal-title":"Br. J. Cancer"},{"key":"10.1016\/S0163-7258(98)00053-9_BIB116","first-page":"1881","article-title":"Effects of cytogenin, a novel microbial product, on embryonic and tumor cell-induced angiogenic responses in vivo.","volume":"17","author":"Oikawa","year":"1997","journal-title":"Anticancer Res."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB117","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1006\/bbrc.1998.8604","article-title":"The proteasome is involved in angiogenesis","volume":"246","author":"Oikawa","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB118","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1073\/pnas.95.7.3609","article-title":"Impact of oncogenes in tumor angiogenesis","volume":"95","author":"Okada","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0163-7258(98)00053-9_BIB119","first-page":"964","article-title":"The effect of thalidomide and 2 analogs on collagen induced arthritis","volume":"25","author":"Oliver","year":"1998","journal-title":"J. Rheumatol."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB120","first-page":"217","article-title":"Thalidomide reduces vascular density in granulation tissue of subcutaneously implanted polyvinyl alcohol sponges in guinea pigs","volume":"26","author":"Or","year":"1998","journal-title":"Exp. Hematol."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB121","first-page":"273","article-title":"Angiostatin","volume":"79","author":"O\u2019Reilly","year":"1997","journal-title":"EXS"},{"key":"10.1016\/S0163-7258(98)00053-9_BIB122","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1101\/SQB.1994.059.01.052","article-title":"Angiostatin","volume":"59","author":"O\u2019Reilly","year":"1994","journal-title":"Cold Spring Harbor Symp. Quant. Biol."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB123","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0092-8674(94)90200-3","article-title":"Angiostatin","volume":"79","author":"O\u2019Reilly","year":"1994","journal-title":"Cell"},{"key":"10.1016\/S0163-7258(98)00053-9_BIB124","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/nm0696-689","article-title":"Angiostatin induces and sustains dormancy of human primary tumors in mice","volume":"2","author":"O\u2019Reilly","year":"1996","journal-title":"Nature Med."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB125","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0092-8674(00)81848-6","article-title":"Endostatin","volume":"88","author":"O\u2019Reilly","year":"1997","journal-title":"Cell"},{"key":"10.1016\/S0163-7258(98)00053-9_BIB126","first-page":"569","article-title":"in vitro biological characterization and antiangiogenic effects of PD 166866, a selective inhibitor of the FGF-1 receptor tyrosine kinase","volume":"286","author":"Panek","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB127","series-title":"Angiogenesis","first-page":"149","article-title":"Angiogenesis in vitro: cytokine interactions and balanced extracellular proteolysis","author":"Pepper","year":"1994"},{"key":"10.1016\/S0163-7258(98)00053-9_BIB128","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1159\/000468622","article-title":"Angiogenesis","volume":"49","author":"Pepper","year":"1996","journal-title":"Enzyme Protein"},{"key":"10.1016\/S0163-7258(98)00053-9_BIB129","first-page":"1523","article-title":"Neutralizing antibodies against epidermal growth factor and ErbB-2\/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors","volume":"151","author":"Petit","year":"1997","journal-title":"Am. J. Pathol."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB130","first-page":"203","article-title":"Tumor-associated angiogenesis","volume":"24","author":"Pluda","year":"1997","journal-title":"Semin. Oncol."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB131","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/(SICI)1097-0045(19980401)35:1<43::AID-PROS6>3.0.CO;2-I","article-title":"Effects of linomide on advanced prostate-seminal vesicle cancers in Lobund-Wistar rats","volume":"35","author":"Pollard","year":"1998","journal-title":"Prostate"},{"key":"10.1016\/S0163-7258(98)00053-9_BIB132","first-page":"2430","article-title":"How the extracellular matrix and macrophages contribute to angiogenesis-dependent diseases","volume":"32A","author":"Polverini","year":"1997","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/S0163-7258(98)00053-9_BIB133","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0065-7743(08)61474-8","article-title":"Angiogenesis inhibitors","volume":"32","author":"Powell","year":"1997","journal-title":"Annu. Rep. Med. Chem."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB134","first-page":"1","article-title":"Complex roles of matrix metalloproteinases in tumor progression","volume":"213","author":"Powell","year":"1996","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB135","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1517\/13543784.7.5.797","article-title":"Basic fibroblast growth factor and the complexity of tumor angiogenesis","volume":"7","author":"Rak","year":"1998","journal-title":"Expert Opin. Invest. Drugs"},{"key":"10.1016\/S0163-7258(98)00053-9_BIB136","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0163-7258(97)00023-5","article-title":"Matrix metalloproteinase inhibition as a novel anticancer strategy","volume":"75","author":"Rasmussen","year":"1997","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB137","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1183\/09031936.94.07112062","article-title":"The role of matrix metalloproteases and their inhibitors in tumor invasion, metastasis and angiogenesis","volume":"7","author":"Ray","year":"1994","journal-title":"Eur. Respir. J."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB138","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0065-2490(97)80015-9","article-title":"Development of estrogen antagonists as pharmaceutical agents","volume":"29","author":"Ray","year":"1997","journal-title":"Adv. Drug Res."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB139","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.2527\/1998.7661671x","article-title":"Expression of the angiogenic factors, basic fibroblast growth factor and vascular endothelial growth factor","volume":"76","author":"Reynolds","year":"1998","journal-title":"J. Anim. Sci."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB140","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0955-2235(90)90010-H","article-title":"Angiogenic growth factor","volume":"2","author":"Risau","year":"1990","journal-title":"Prog. Growth Factor Res."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB141","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/bjc.1998.148","article-title":"Hypoxia-induced angiogenesis and vascular endothelial growth factor secretion in human melanoma","volume":"77","author":"Rofstad","year":"1998","journal-title":"Br. J. Cancer"},{"key":"10.1016\/S0163-7258(98)00053-9_BIB142","first-page":"218a","article-title":"Phase I trial of SU5416, a novel angiogenesis inhibitor in patients with advanced malignancies","volume":"17","author":"Rosen","year":"1998","journal-title":"Proc. Am. Soc. Clin. Oncol."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB143","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1136\/mp.51.2.55","article-title":"Response of tumor cells to hypoxia","volume":"51","author":"Royds","year":"1998","journal-title":"Mol. Pathol."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB144","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1023\/A:1018418725453","article-title":"Rodent pharmacokinetic and anti-tumor efficacy studies with a series of synthetic inhibitors of matrix metalloproteinases","volume":"15","author":"Santos","year":"1997","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/S0163-7258(98)00053-9_BIB145","first-page":"462","article-title":"Angiogenesis inhibitor TNP-470 inhibits human breast cancer osteolytic bone metastasis in nude mice through the reduction of bone resorption","volume":"58","author":"Sasaki","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB146","doi-asserted-by":"crossref","first-page":"6127","DOI":"10.1016\/S0040-4039(97)01389-0","article-title":"Synthesis of a CD-ring analog of 17 \u03b1-hydroxyprogesterone","volume":"38","author":"Schweiger","year":"1997","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB147","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/(SICI)1097-0215(19980302)75:5<706::AID-IJC8>3.0.CO;2-2","article-title":"Role of the hypoxia sensing system, acidity and reproductive hormones in the variability of vascular endothelial growth factor induction in human breast carcinoma cell lines","volume":"75","author":"Scott","year":"1998","journal-title":"Int. J. Cancer"},{"issue":"Suppl. 4","key":"10.1016\/S0163-7258(98)00053-9_BIB148","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/0026-0495(95)90217-1","article-title":"Intracellular signaling by growth factors","volume":"44","author":"Seedorf","year":"1995","journal-title":"Metab. Clin. Exp."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB149","first-page":"F21","article-title":"Progress in understanding the molecular pathogenesis of human lung cancer","volume":"1378","author":"Sekido","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/S0163-7258(98)00053-9_BIB150","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S1359-6446(96)10053-2","article-title":"Receptor tyrosine kinases as targets for inhibition of angiogenesis","volume":"2","author":"Shawver","year":"1997","journal-title":"Drug Discov. Today"},{"key":"10.1016\/S0163-7258(98)00053-9_BIB151","doi-asserted-by":"crossref","first-page":"6788","DOI":"10.1073\/pnas.92.15.6788","article-title":"Thrombospondin 1 expression in transformed endothelial cells restores a normal phenotype and suppresses their tumorigenesis","volume":"92","author":"Sheibani","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0163-7258(98)00053-9_BIB152","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1126\/science.6199844","article-title":"Heparin affinity","volume":"223","author":"Shing","year":"1984","journal-title":"Science"},{"key":"10.1016\/S0163-7258(98)00053-9_BIB153","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0163-7258(97)00097-1","article-title":"Small molecule inhibitors of the platelet-derived growth factor receptor, the fibroblast growth factor receptor, and Src family tyrosine kinases","volume":"76","author":"Showalter","year":"1997","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB154","first-page":"2784","article-title":"Squalamine inhibits angiogenesis and solid tumor growth in vivo and perturbs embryonic vasculature","volume":"58","author":"Sills","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB155","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1023\/A:1005826129756","article-title":"Inhibition of tumor growth and metastasis by angiogenesis inhibitor TNP-470 on breast cancer cell lines in vitro and in vivo.","volume":"45","author":"Singh","year":"1997","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB156","first-page":"799","article-title":"Identification and characterization of human metabolites of CAI [5-amino-1-(4\u2032-chlorobenzoyl-3,5-dichlorobenzyl)-1,2,3-triazole-4-carboxamide]","volume":"24","author":"Soltis","year":"1996","journal-title":"Drug Metab. Dispos."},{"issue":"Sect. A","key":"10.1016\/S0163-7258(98)00053-9_BIB157","first-page":"1","article-title":"Cancer war may have new weapon","volume":"May 4,","author":"Sternberg","year":"1998","journal-title":"USA Today"},{"key":"10.1016\/S0163-7258(98)00053-9_BIB158","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1517\/13543784.7.4.553","article-title":"Tyrosine kinases in disease","volume":"7","author":"Strawn","year":"1998","journal-title":"Expert Opin. Invest. Drugs"},{"key":"10.1016\/S0163-7258(98)00053-9_BIB159","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1021\/jm980123i","article-title":"Synthesis and biological evaluations of 3-substituted indolin-2-ones","volume":"41","author":"Sun","year":"1998","journal-title":"J. Med. Chem."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB160","unstructured":"Sun, L., Tran, N., Tang, F., Schreck, R., Annie, T., Fong, T., McMahon, G. and Tang, C. (1998b) Synthesis and biological evaluation of novel 3-(substituted pyrrol-2-yl)indolin-2-ones as potent and selective inhibitors of the Flk-1\/KDR receptor tyrosine kinase. In: Abstracts of the 215th American Chemical Society National Meeting, Dallas, March 29\u2013April 2, p. MEDI-169, American Chemical Society, Washington, DC."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB161","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0022-5347(01)65250-9","article-title":"Angiogenesis inhibitor TNP-470 suppresses tumorigenesis in rat urinary bladder","volume":"157","author":"Tanaka","year":"1997","journal-title":"J. Urol."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB162","unstructured":"Tang, C., Li, S., Tran, J., Liang, C., Nematalla, A., Fong, A., App, H., Rice, A., Kim, Y., Schreck, R., Chen, J., Dowd, B., Suto, E., Vasile, S., Shawver, L., McMahon, J. and Hirth, P. (1998) SU5416: a potent and selective Flk-1\/KDR kinase inhibitor that blocks receptor autophosphorylation, endothelial cell mitogenesis, and tumor growth. In: Abstracts of the 215th American Chemical Society National Meeting, Dallas, March 29\u2013April 2, p. MEDI-205, American Chemical Society, Washington, DC."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB163","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/BF00437479","article-title":"A systems approach to cancer therapy. (Antiangiogenics + standard cytotoxics \u2192 mechanism(s) of interaction)","volume":"15","author":"Teicher","year":"1996","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB164","unstructured":"Thomas, A. P., Hennequin, L. F. A. and Johnstone, C. (1997a) Preparation of 4-anilinoquinazolines for use in the treatment of disease states associated with antiangiogenesis and\/or increased vascular permeability. World Patent Application WO 9732856."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB165","unstructured":"Thomas, A. P., Johnstone, C. and Hennequin, L. F. A. (1997b) Preparation of quinazolines as VEGF inhibitors. World Patent Application WO 9730035."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB166","unstructured":"Thomas, A. P., Hennequin, L. F. A. and Ple, P. A. (1998) Quinoline derivatives inhibiting the effect of growth factors such as VEGF. World Patent Application WO 9813350."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB167","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1517\/13543776.7.6.571","article-title":"Protein tyrosine kinase inhibitors in cancer treatment","volume":"7","author":"Traxler","year":"1997","journal-title":"Expert Opin. Ther. Patents"},{"key":"10.1016\/S0163-7258(98)00053-9_BIB168","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1021\/jm970634p","article-title":"Development of a binding model to protein tyrosine kinases for substituted pyrido[2,3-d]pyrimidine inhibitors","volume":"41","author":"Trumpp-Kallmeyer","year":"1998","journal-title":"J. Med. Chem."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB169","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/00001622-199711000-00015","article-title":"Clinical trials of antiangiogenic agents","volume":"9","author":"Twardowski","year":"1997","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB170","series-title":"Die Krankhaften Geschwulste","author":"Virchow","year":"1863"},{"key":"10.1016\/S0163-7258(98)00053-9_BIB171","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1073\/pnas.84.8.2292","article-title":"Endothelial cell-derived basic fibroblast growth factor","volume":"84","author":"Vlodavsky","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0163-7258(98)00053-9_BIB172","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/00001813-199609000-00001","article-title":"Inhibitors of angiogenesis in a clinical perspective","volume":"7","author":"Voest","year":"1996","journal-title":"Anticancer Drugs"},{"key":"10.1016\/S0163-7258(98)00053-9_BIB173","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1038\/sj.onc.1200977","article-title":"Sequential development of an angiogenic phenotype by human fibroblasts progressing to tumorgenicity","volume":"14","author":"Volpert","year":"1997","journal-title":"Oncogene"},{"key":"10.1016\/S0163-7258(98)00053-9_BIB174","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/nm0897-887","article-title":"Antisense targeting of basic fibroblast growth factor and fibroblast growth factor receptor-1 in human melanomas blocks intratumoral angiogenesis and tumor growth","volume":"3","author":"Wang","year":"1997","journal-title":"Nature Med."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB175","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1203\/00006450-199703000-00004","article-title":"The angiogenesis inhibitor TNP-470 reduces the growth rate of human neuroblastoma in nude rats","volume":"41","author":"Wassberg","year":"1997","journal-title":"Pediatr. Res."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB176","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/scientificamerican0996-62","article-title":"How cancer arises","volume":"275","author":"Weinberg","year":"1996","journal-title":"Sci. Am."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB177","first-page":"6504","article-title":"Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis","volume":"54","author":"Weinstat-Saslow","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB178","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1200\/JCO.1998.16.6.2150","article-title":"Phase I trial of marimastat, a novel matrix metalloproteinase inhibitor, administered orally to patients with advanced lung cancer","volume":"16","author":"Wojtowicz-Praga","year":"1998","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB179","first-page":"1915","article-title":"Inhibition of head and neck squamous cell carcinoma growth and invasion by the calcium influx inhibitor carboxyamido-triazole","volume":"3","author":"Wu","year":"1997","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB180","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/BF01240121","article-title":"Inhibitory effect of the angiogenesis inhibitor TNP-470 on tumor growth and metastasis in nude mice bearing human hepatocellular carcinoma","volume":"123","author":"Xia","year":"1997","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB181","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3109\/09513599709152564","article-title":"Expression of vascular endothelial growth factor (VEGF) during folliculogenesis and corpus luteum formation in the human ovary","volume":"11","author":"Yamamoto","year":"1997","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB182","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/jnci\/90.6.447","article-title":"Expression of angiogenesis-related genes and progression of human ovarian carcinomas in nude mice","volume":"90","author":"Yoneda","year":"1998","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB183","doi-asserted-by":"crossref","first-page":"9533","DOI":"10.1073\/pnas.85.24.9533","article-title":"Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells","volume":"85","author":"Young","year":"1988","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0163-7258(98)00053-9_BIB184","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1124\/mol.51.6.951","article-title":"2-Methoxyestradiol, an endogenous estrogen metabolite, induces apoptosis in endothelial cells and inhibits angiogenesis","volume":"51","author":"Yue","year":"1997","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB185","doi-asserted-by":"crossref","first-page":"624","DOI":"10.2174\/1381612802666221004190555","article-title":"Inhibition of matrix metalloproteinases","volume":"2","author":"Zask","year":"1996","journal-title":"Curr. Pharm. Design"},{"key":"10.1016\/S0163-7258(98)00053-9_BIB186","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1146\/annurev.med.49.1.407","article-title":"Angiogenesis and tumor metastasis","volume":"49","author":"Zetter","year":"1998","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/S0163-7258(98)00053-9_BIB187","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/bjc.1998.186","article-title":"Linomide blocks angiogenesis by breast carcinoma vascular endothelial growth factor transfectants","volume":"77","author":"Ziche","year":"1998","journal-title":"Br. J. Cancer"},{"key":"10.1016\/S0163-7258(98)00053-9_BIB188","unstructured":"Zook, S. E., Dagnino, R. J., Deason, M. E., Bender, S. L. and Melnick, M. J. (1997) Metalloproteinase inhibitors. Pharmaceutical compositions containing them and their pharmaceutical uses, and methods and intermediates useful for their preparation. World Patent Application WO 9720824."}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725898000539?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725898000539?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T07:57:50Z","timestamp":1704182270000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725898000539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,5]]},"references-count":188,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[1999,5]]}},"alternative-id":["S0163725898000539"],"URL":"https:\/\/doi.org\/10.1016\/s0163-7258(98)00053-9","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[1999,5]]}}}